GP-1002

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameGP-1002
Drug Alias NameGPCR agonist (Gemmus)immunomodulator (Gemmus Pharma)GP-1002
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionG-protein coupled receptor agonists
TargetsG-protein coupled receptor
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGemmus
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGemmus
Active IndicationsN/A
Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A
Related LinksN/A